rs35859650

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 5P and 2B. PS3PP3BP4_Moderate

The NM_000036.3(AMPD1):​c.1162C>T​(p.Arg388Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000369 in 1,613,898 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000617307: Published functional studies demonstrate a damaging effect" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R388Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00021 ( 1 hom. )

Consequence

AMPD1
NM_000036.3 missense

Scores

12
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:3B:1

Conservation

PhyloP100: 2.85

Publications

7 publications found
Variant links:
Genes affected
AMPD1 (HGNC:468): (adenosine monophosphate deaminase 1) Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
AMPD1 Gene-Disease associations (from GenCC):
  • myopathy due to myoadenylate deaminase deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • adenosine monophosphate deaminase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000617307: Published functional studies demonstrate a damaging effect; specifically, expression studies of this variant form of AMPD1 in prokaryotic cells demonstrated undetectable enzyme activity despite normal quantities of AMPD1 peptides, as compared with controls (PMID: 11102975)
PP3
Multiple lines of computational evidence support a deleterious effect 10: AlphaMissense, BayesDel_noAF, Cadd, Dann, M_CAP, MutationAssessor, PrimateAI, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster, phyloP100way_vertebrate was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.07670745).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000036.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AMPD1
NM_000036.3
MANE Select
c.1162C>Tp.Arg388Trp
missense
Exon 9 of 16NP_000027.3P23109-1
AMPD1
NM_001172626.2
c.1150C>Tp.Arg384Trp
missense
Exon 8 of 15NP_001166097.2P23109-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AMPD1
ENST00000520113.7
TSL:1 MANE Select
c.1162C>Tp.Arg388Trp
missense
Exon 9 of 16ENSP00000430075.3P23109-1
AMPD1
ENST00000369538.4
TSL:2
c.1150C>Tp.Arg384Trp
missense
Exon 8 of 15ENSP00000358551.4P23109-2
AMPD1
ENST00000637080.1
TSL:5
n.*369C>T
non_coding_transcript_exon
Exon 7 of 14ENSP00000489753.1A0A1B0GTL6

Frequencies

GnomAD3 genomes
AF:
0.00192
AC:
292
AN:
151998
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00669
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000565
AC:
142
AN:
251462
AF XY:
0.000397
show subpopulations
Gnomad AFR exome
AF:
0.00726
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000207
AC:
303
AN:
1461782
Hom.:
1
Cov.:
33
AF XY:
0.000169
AC XY:
123
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.00627
AC:
210
AN:
33480
American (AMR)
AF:
0.000358
AC:
16
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39698
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86258
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53392
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000189
AC:
21
AN:
1111930
Other (OTH)
AF:
0.000497
AC:
30
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00193
AC:
293
AN:
152116
Hom.:
1
Cov.:
31
AF XY:
0.00186
AC XY:
138
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.00670
AC:
278
AN:
41512
American (AMR)
AF:
0.000393
AC:
6
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4810
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68000
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000714
Hom.:
0
Bravo
AF:
0.00213
ESP6500AA
AF:
0.00499
AC:
22
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000675
AC:
82
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
1
Muscle AMP deaminase deficiency (3)
1
2
-
not provided (3)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Uncertain
0.074
D
BayesDel_noAF
Pathogenic
0.34
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.077
T
MetaSVM
Uncertain
0.77
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
2.9
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.82
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.99
MVP
0.98
MPC
0.46
ClinPred
0.12
T
GERP RS
1.9
Varity_R
0.86
gMVP
0.95
Mutation Taster
=44/56
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35859650; hg19: chr1-115220593; COSMIC: COSV100814994; COSMIC: COSV100814994; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.